BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35152537)

  • 1. MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT.
    Meng J; Xu C
    J Cell Mol Med; 2022 Apr; 26(7):2076-2088. PubMed ID: 35152537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-143 Increases Oxidative Stress and Myocardial Cell Apoptosis in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity.
    Li XQ; Liu YK; Yi J; Dong JS; Zhang PP; Wan L; Li K
    Med Sci Monit; 2020 Mar; 26():e920394. PubMed ID: 32170053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
    Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
    Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
    Fan D; Chen HB; Leng Y; Yang SJ
    Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.
    Xu C; Liu CH; Zhang DL
    Biochem Biophys Res Commun; 2020 Jan; 521(2):485-491. PubMed ID: 31677784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity.
    Wang JX; Zhang XJ; Feng C; Sun T; Wang K; Wang Y; Zhou LY; Li PF
    Cell Death Dis; 2015 Mar; 6(3):e1677. PubMed ID: 25766316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
    Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
    Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
    Zhang WB; Lai X; Guo XF
    Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1.
    Zhao X; Jin Y; Li L; Xu L; Tang Z; Qi Y; Yin L; Peng J
    Pharmacol Res; 2019 Aug; 146():104276. PubMed ID: 31112750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
    Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
    Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
    Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
    J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
    Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
    Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice.
    Ye P; Li WL; Bao LT; Ke W
    Oxid Med Cell Longev; 2022; 2022():2967142. PubMed ID: 35847586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
    Fu Q; Pan H; Tang Y; Rong J; Zheng Z
    Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.